CN103998625A - 用于病毒检测的方法和系统 - Google Patents
用于病毒检测的方法和系统 Download PDFInfo
- Publication number
- CN103998625A CN103998625A CN201180074939.7A CN201180074939A CN103998625A CN 103998625 A CN103998625 A CN 103998625A CN 201180074939 A CN201180074939 A CN 201180074939A CN 103998625 A CN103998625 A CN 103998625A
- Authority
- CN
- China
- Prior art keywords
- dna
- sequence
- sequencing library
- dna sequencing
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 67
- 241000700605 Viruses Species 0.000 title claims abstract description 48
- 238000001514 detection method Methods 0.000 title abstract description 20
- 238000001712 DNA sequencing Methods 0.000 claims abstract description 124
- 230000003612 virological effect Effects 0.000 claims abstract description 55
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 44
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 40
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 40
- 238000005516 engineering process Methods 0.000 claims abstract description 31
- 108020004414 DNA Proteins 0.000 claims description 244
- 239000002773 nucleotide Substances 0.000 claims description 85
- 125000003729 nucleotide group Chemical group 0.000 claims description 85
- 238000012163 sequencing technique Methods 0.000 claims description 74
- 238000006243 chemical reaction Methods 0.000 claims description 53
- 238000000926 separation method Methods 0.000 claims description 37
- 239000006249 magnetic particle Substances 0.000 claims description 31
- 238000004519 manufacturing process Methods 0.000 claims description 29
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 102000053602 DNA Human genes 0.000 claims description 17
- 238000012408 PCR amplification Methods 0.000 claims description 17
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 14
- 238000003745 diagnosis Methods 0.000 claims description 12
- 239000007762 w/o emulsion Substances 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 10
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 6
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 6
- 238000013519 translation Methods 0.000 claims description 6
- 230000004087 circulation Effects 0.000 claims description 5
- 239000006166 lysate Substances 0.000 claims description 5
- 239000011049 pearl Substances 0.000 claims description 5
- 238000011084 recovery Methods 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000001962 electrophoresis Methods 0.000 claims description 4
- 241001504639 Alcedo atthis Species 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 2
- 241000701806 Human papillomavirus Species 0.000 claims description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 2
- 201000010881 cervical cancer Diseases 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 description 43
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 description 34
- 239000000203 mixture Substances 0.000 description 24
- 239000000047 product Substances 0.000 description 18
- 241000341655 Human papillomavirus type 16 Species 0.000 description 10
- 238000003205 genotyping method Methods 0.000 description 9
- 239000007795 chemical reaction product Substances 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 206010016825 Flushing Diseases 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 208000019065 cervical carcinoma Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 1
- 108091036060 Linker DNA Proteins 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 208000009608 Papillomavirus Infections Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000003837 Second Primary Neoplasms Diseases 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000009415 formwork Methods 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000011079 streamline operation Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
提供了用于病毒检测的方法和系统。其中，用于病毒检测的方法包括以下步骤：针对包含病毒核酸的样品，制备DNA测序文库；利用Ion Torrent技术对所述DNA测序文库进行DNA测序，以便获得所述病毒核酸的序列信息；以及基于所述病毒核酸的序列信息确定所述病毒的类型。
Description
PCT国内申请，说明书已公开。
Claims (1)
- PCT国内申请，权利要求书已公开。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2011/082492 WO2013071520A1 (zh) | 2011-11-18 | 2011-11-18 | 用于病毒检测的方法和系统 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103998625A true CN103998625A (zh) | 2014-08-20 |
| CN103998625B CN103998625B (zh) | 2017-06-06 |
Family
ID=48428953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201180074939.7A Active CN103998625B (zh) | 2011-11-18 | 2011-11-18 | 用于病毒检测的方法和系统 |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN103998625B (zh) |
| TW (1) | TW201321520A (zh) |
| WO (1) | WO2013071520A1 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106103742A (zh) * | 2015-01-06 | 2016-11-09 | 深圳市海普洛斯生物科技有限公司 | 一种富集循环肿瘤dna的方法和试剂 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104651352A (zh) * | 2013-11-15 | 2015-05-27 | 苏州吉玛基因股份有限公司 | 一种用于高通量测序分析dna甲基化状态的文库构建方法 |
| CN107208314B (zh) * | 2015-01-06 | 2020-06-16 | 深圳华大智造科技有限公司 | 一种单体型分型测序文库的构建方法、分型方法和试剂 |
| KR102489353B1 (ko) | 2015-06-01 | 2023-01-17 | 캘리포니아 인스티튜트 오브 테크놀로지 | 특정 집단에 대한 항원으로 t 세포를 스크리닝하기 위한 조성물 및 방법 |
| CN110407911A (zh) * | 2018-04-28 | 2019-11-05 | 南京金斯瑞生物科技有限公司 | 磁珠纯化系统 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101921874A (zh) * | 2010-06-30 | 2010-12-22 | 深圳华大基因科技有限公司 | 基于Solexa测序法的检测人类乳头瘤病毒的方法 |
-
2011
- 2011-11-18 CN CN201180074939.7A patent/CN103998625B/zh active Active
- 2011-11-18 WO PCT/CN2011/082492 patent/WO2013071520A1/zh active Application Filing
-
2012
- 2012-11-12 TW TW101142069A patent/TW201321520A/zh unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101921874A (zh) * | 2010-06-30 | 2010-12-22 | 深圳华大基因科技有限公司 | 基于Solexa测序法的检测人类乳头瘤病毒的方法 |
Non-Patent Citations (2)
| Title |
|---|
| 王升启: "基因芯片技术及应用研究进展", 《中国生物工程杂志》 * |
| 王山鸣: "应用第二代DNA测序技术于遗传性疾病的研究", 《山东大学学报，医学版》, vol. 49, no. 10, 30 October 2011 (2011-10-30), pages 44 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106103742A (zh) * | 2015-01-06 | 2016-11-09 | 深圳市海普洛斯生物科技有限公司 | 一种富集循环肿瘤dna的方法和试剂 |
| CN106103742B (zh) * | 2015-01-06 | 2019-12-10 | 深圳市海普洛斯生物科技有限公司 | 一种富集循环肿瘤dna的方法和试剂 |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201321520A (zh) | 2013-06-01 |
| CN103998625B (zh) | 2017-06-06 |
| WO2013071520A1 (zh) | 2013-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Steinau et al. | Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues | |
| JP7323532B2 (ja) | 短い核酸断片の単離、精製及び／又は濃縮のために水性二相系を使用する方法 | |
| Hosseini et al. | Roadmap to the bioanalytical testing of COVID-19: from sample collection to disease surveillance | |
| CN103998625A (zh) | 用于病毒检测的方法和系统 | |
| JP2007525982A5 (zh) | ||
| WO2018133546A1 (zh) | 无创产前胎儿α型地贫基因突变检测文库构建方法、检测方法和试剂盒 | |
| WO2018184495A1 (zh) | 一步法构建扩增子文库的方法 | |
| US20190225958A1 (en) | Method for enrichment and purification of cell-free dna from body fluid for high-throughput processing | |
| Cler et al. | A comparison of five methods for extracting DNA from paucicellular clinical samples | |
| WO2018133547A1 (zh) | 无创产前胎儿β型地贫基因突变检测文库构建方法、检测方法和试剂盒 | |
| JP2023021395A (ja) | ホルムアルデヒドを含有する液体系細胞診用保存剤中検体から核酸を単離する方法 | |
| EP0489442A1 (en) | Synthetic oligonucleotides useful for the diagnosis of infections from different types of virus of the papilloma group and usage thereof | |
| CN108130359A (zh) | 一种dna甲基化检测试剂盒及其应用 | |
| JP4388061B2 (ja) | Ｅ型肝炎ウイルスを検出するためのｌａｍｐ増幅用核酸プライマーセット | |
| CN109266723A (zh) | 稀有突变检测方法、其试剂盒及应用 | |
| CN106834487A (zh) | 快速筛查p53基因外显子5‑8突变的体外检测方法及应用 | |
| CN101906414A (zh) | 甲基化dna的浓缩方法和检测方法以及试剂盒 | |
| KR20220077907A (ko) | 라이브러리 구축 방법 및 응용 | |
| KR101152840B1 (ko) | Ｈｐｖ 유전자형 진단용 프로브 및 그 분석방법 | |
| CN102209793A (zh) | 用于检测hpv的核苷酸序列、方法和试剂盒 | |
| CN110144345A (zh) | 一种从卵泡液中提取cfDNA的方法 | |
| Oh et al. | Improved DNA extraction method for molecular diagnosis from smaller numbers of cells | |
| CN107385092A (zh) | 一种检测vhl基因突变的固相pcr试剂盒 | |
| Dutta et al. | Nucleic Acid in Diagnostics | |
| CN113699213A (zh) | 一种用于二代测序文库构建方法及试剂盒 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20140820 Assignee: Huada biological technology (Wuhan) Co., Ltd. Assignor: BGI-Shenzhen Co., Ltd. Contract record no.: 2014990000825 Denomination of invention: Method and system of virus detection License type: Exclusive License Record date: 20141030 |
|
| LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
| ASS | Succession or assignment of patent right |
Owner name: SHENZHEN BGI CORPORATION Free format text: FORMER OWNER: BGI-SHENZHEN CO., LTD. Effective date: 20150805 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20150805 Address after: Yantian District of Shenzhen City, Guangdong province 518083 Hongan street No. 21 China Comprehensive Park 7 Building 7 layer -14 layer Applicant after: BGI SHENZHEN CO LTD Address before: North Road No. 146, building 11F-3 Industrial Zone in Yantian District of Shenzhen city of Guangdong Province in 518083 Applicant before: BGI-Shenzhen Co., Ltd. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160822 Address after: 430075 East Lake high tech Development Zone, Wuhan, Hubei high tech Avenue, No. 666 Wuhan national biological industry base project B, C, D District R & D building B2 Applicant after: Huada biological technology (Wuhan) Co., Ltd. Address before: Yantian District of Shenzhen City, Guangdong province 518083 Hongan street No. 21 China Comprehensive Park 7 Building 7 layer -14 layer Applicant before: BGI SHENZHEN CO LTD |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20191105 Address after: Building w2a, building B, building a, building 201203a5, high tech Industrial Village, No. 025, South 4th Road, high tech Zone, Yuehai street, Nanshan District, Shenzhen City, Guangdong Province Patentee after: Shenzhen Huada Yinyuan Pharmaceutical Technology Co., Ltd Address before: 430075 East Lake high tech Development Zone, Wuhan, Hubei high tech Avenue, No. 666 Wuhan national biological industry base project B, C, D District R & D building B2 Patentee before: Huada Biotechnology (Wuhan) Co., Ltd. |